NCT02376283View on ClinicalTrials.gov

P3AMI Antiplatelet Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

March 9, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Heart Attack
Interventions
DRUG

Prasugrel

DRUG

Clopidogrel

DRUG

ticagrelor

Trial Locations (1)

WV10 0QP

The Royal Wolverhampton NHS Trust, Wolverhampton

All Listed Sponsors
lead

The Royal Wolverhampton Hospitals NHS Trust

OTHER_GOV

NCT02376283 - P3AMI Antiplatelet Trial | Biotech Hunter | Biotech Hunter